Price $18.69 |
Market Cap
495M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
7.6
|
P/B
1.82
|
P/S
1.97
|
Dividend %
-
|
|
P/CF
6.3
|
P/FCF
4.6
|
Op. Cash Flow
132.8K
|
FCF
4.2
|
|
Op. Margin
29.50%
|
Net Margin
30.40%
|
ROE
31.20%
|
ROI
3.30%
|
|
ROA
19.50%
|
EPS Growth
148.20%
|
Current Ratio
3.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | $13.41 | - | - | 139.2M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Dynatronics Corp (DYNT) | $0.15 | - | - | 2.4M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
